CalciMedica, Inc.CALCNASDAQ
Loading
SG&A Expense Growth Recovery in ProgressRecovering
Percentile Rank20
Studio
Year-over-Year Change

Year-over-year SG&A expense growth

Percentile
P20
Within normal range
vs 5Y Ago
-0.4x
Contraction
Streak
1 qtr
Consecutive growthRecovering
PeriodValue
Q4 2025-27.67%
Q3 2025-31.22%
Q2 202513.02%
Q1 2025-2.32%
Q4 20246.26%
Q3 2024-7.67%
Q2 2024-15.98%
Q1 202483.67%
Q4 2023-25.42%
Q3 2023-25.57%
Q2 2023-12.07%
Q1 2023166.19%
Q4 2022-42.12%
Q3 202255.20%
Q2 20222.41%
Q1 2022-2.80%
Q4 2021-66.89%
Q3 202111.78%
Q2 2021-29.07%
Q1 202136.70%
Q4 202078.63%
Q3 202046.59%
Q2 2020-17.71%
Q1 2020-32.05%
Q4 201928.34%
Q3 20190.00%